L. Jim Thomas
GET UPDATES FROM L. Jim Thomas
 
Jim Thomas is Research Director with the ETC Group, an international technology watchdog that tracks emerging technologies, corporate power, agriculture and biodiversity. He writes about the social and environmental impacts of Biotechnology, Nanotechnology, Synthetic Biology and Geoengineering as well as the corporate and government strategies around these technologies. Jim is co-author of several ETC Group reports and the book Earth Grab published by Pambazuka Press.

Entries by L. Jim Thomas

GMOs 2.0: A New Generation Of Fake Food And Fake Promises

(41) Comments | Posted September 21, 2016 | 11:48 AM

Would you put these items on your shopping list?

Gene-silenced apples that don't rot; synthetic vanilla made with genetically engineered yeast; canola, DNA edited to resist pesticides.

These are just a few of the new genetically engineered products already making their way to...

Read Post

The Campaign Kickstarter Shouldn't Be Funding

(0) Comments | Posted June 6, 2013 | 11:06 AM

There is less than a day to go before the popular crowdfunding site Kickstarter.com hands hundreds of thousands of dollars to a controversial project for the widespread and unregulated distribution of over half a million extreme-bioengineered seeds .

I already wrote about the...

Read Post

Don't Dump Iron -- Dump Rogue Climate Schemes

(3) Comments | Posted May 24, 2013 | 12:04 PM

The press release had a pretty stark headline: "Haida Announce Termination of Russ George." If the name sounds familiar its because he is the Californian businessman who last year led the world's largest, and unapproved, geoengineering (climate manipulation) scheme to dump over 100 tonnes of iron...

Read Post

Biohackers Are Kickstarting Some Unregulated Experiments

(29) Comments | Posted May 10, 2013 | 11:56 AM

You may have heard of Kickstarter -- the darling crowdfunding site where artists, designers, moviemakers, and others pitch pet projects to an online funder audience. Kickstarter may have just taken on a new and unwelcome role -- as the one-stop shop for risky biotech companies looking to execute...

Read Post